GlassScriptPhysician profile
Carla Cantor
NPI 1609186295
$1,903.08
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,007 · 2022: $786 · 2023: $65.36 · 2024: $44.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $109.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $282.97 | 2021-2023 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals LP | $238.56 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $193.15 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $167.88 | 2021 | |
| Lilly USA, LLC | $111.21 | 2021-2022 | |
| Amgen INC. | $98.32 | 2021-2022 | |
| Seagen INC. | $93.22 | 2021-2023 | Adcetris |
| Pfizer INC. | $66.69 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.50 | 2022-2023 | Alunbrig |
| Daiichi Sankyo INC. | $51.66 | 2021-2022 | |
| Tersera Therapeutics LLC | $48.40 | 2021-2022 | |
| Genzyme Corporation | $45.34 | 2021-2022 | |
| Janssen Biotech, INC. | $44.34 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $42.41 | 2021 | |
| Incyte Corporation | $33.70 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $32.25 | 2022 | |
| Genentech USA, INC. | $29.57 | 2022 | |
| Glaxosmithkline, LLC. | $28.27 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $27.61 | 2021 | |
| Pharmacosmos Therapeutics INC. | $26.41 | 2022 | |
| Eisai INC. | $23.50 | 2022 | |
| Kyowa Kirin, INC. | $23.16 | 2021 | |
| Servier Pharmaceuticals LLC | $22.96 | 2022 | |
| Abbvie INC. | $22.64 | 2024 | |
| Array Biopharma INC | $21.90 | 2022 | |
| Boston Scientific Corporation | $21.87 | 2024 | Spaceoar Vue System - 10ml |
| Ge Healthcare | $18.26 | 2022 | |
| Organon LLC | $16.92 | 2022 | |
| Morphosys, US INC. | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Cantor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.